Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PRPH

ProPhase Labs Inc

Apr 19 • 04:00PM ET

5.26

Dollar change -0.18
Percentage change -3.31	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC AVSC BSVO AVUS DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	22.06%	Shs Outstand	18.05M	Perf Week	-19.33%
Market Cap	94.94M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	14.07M	Perf Month	-4.88%
Income	-16.78M	PEG	-	EPS next Q	-0.26	Inst Own	9.37%	Short Float	1.83%	Perf Quarter	6.26%
Sales	44.38M	P/S	2.14	EPS this Y	9.69%	Inst Trans	30.18%	Short Ratio	5.24	Perf Half Y	14.10%
Book/sh	2.74	P/B	1.92	EPS next Y	-	ROA	-18.69%	Short Interest	0.26M	Perf Year	-32.99%
Cash/sh	0.29	P/C	17.98	EPS next 5Y	-	ROE	-29.70%	52W Range	4.05 - 9.94	Perf YTD	16.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-47.90%	ROI	-24.69%	52W High	-47.09%	Beta	-0.21
Dividend TTM	-	Quick Ratio	2.10	Sales past 5Y	91.63%	Gross Margin	36.59%	52W Low	29.88%	ATR (14)	0.55
Dividend Ex-Date	May 24, 2022	Current Ratio	2.28	EPS Y/Y TTM	-179.97%	Oper. Margin	-48.70%	RSI (14)	41.77	Volatility	15.44% 8.53%
Employees	113	Debt/Eq	0.43	Sales Y/Y TTM	-63.81%	Profit Margin	-37.81%	Recom	1.00	Target Price	11.00
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-221.40%	Payout	-	Rel Volume	2.02	Prev Close	5.44
Sales Surprise	-59.40%	EPS Surprise	-96.15%	Sales Q/Q	-83.97%	Earnings	Mar 15 BMO	Avg Volume	49.07K	Price	5.26
SMA20	-17.42%	SMA50	-4.64%	SMA200	0.33%	Trades		Volume	99,267	Change	-3.31%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-20-21	Initiated	H.C. Wainwright	Buy	$12
Oct-13-21	Downgrade	Dawson James	Buy → Neutral
Jan-20-21	Initiated	Dawson James	Buy	$25

Apr-16-24 08:00AM	ProPhase Labs Unveils Project ZenQ-AI (GlobeNewswire) +19.42%
Apr-10-24 08:00AM	ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024 (GlobeNewswire)
Apr-01-24 09:00PM	ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.87%
Mar-18-24 09:20AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:08AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
12:53PM	Loading…
Mar-15-24 12:53PM	PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
08:00AM	ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives (GlobeNewswire)
Mar-08-24 08:00AM	PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024 (GlobeNewswire)
Feb-21-24 08:00AM	Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
Feb-20-24 08:00AM	ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART (GlobeNewswire)
Feb-14-24 08:00AM	ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir (GlobeNewswire)
Feb-08-24 08:00AM	Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI) (GlobeNewswire)
Jan-30-24 08:00AM	ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics (GlobeNewswire)
Jan-23-24 08:00AM	Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts (GlobeNewswire)
Jan-04-24 08:00AM	ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024 (GlobeNewswire)
01:50PM	Loading…
Nov-10-23 01:50PM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript (Insider Monkey) -10.78%
Nov-09-23 09:25AM	ProPhase Labs Inc (PRPH) Reports Mixed Q3 Results Amid Strategic Transformations (GuruFocus.com) +7.82%
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023 (GlobeNewswire)
Nov-02-23 08:00AM	ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire)
Oct-17-23 08:00AM	ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output. (GlobeNewswire)
Oct-12-23 08:25AM	DSS Inc. Issues Letter to Shareholders (GlobeNewswire)
08:00AM	ProPhase Labs to Present at The ThinkEquity Conference (GlobeNewswire)
Aug-10-23 10:40AM	ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call. (GlobeNewswire) -9.89%
09:30AM	ProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023 (GlobeNewswire)
Aug-03-23 08:00AM	ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound (GlobeNewswire)
Aug-02-23 08:00AM	ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire)
Jun-29-23 08:00AM	Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea (GlobeNewswire)
Jun-22-23 08:30AM	ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies (GlobeNewswire)
Jun-09-23 08:00AM	Diamond Equity Research to Host Global Select Emerging Growth Invitational Virtual Investor Conference on June 13th, 2023 (GlobeNewswire)
08:00AM	Loading…
Jun-07-23 08:00AM	ProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023 (GlobeNewswire)
Jun-01-23 08:30AM	ProPhase Labs Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing (GlobeNewswire)
May-11-23 09:35AM	ProPhase Labs, Inc. (PRPH) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023 (GlobeNewswire)
May-08-23 08:30AM	ProPhase Labs hires Dr. Matthew Halpert to Drive Companys Key Therapeutic and Diagnostic Oncology Programs (GlobeNewswire)
May-04-23 08:30AM	ProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire) -9.64%
May-03-23 08:30AM	ProPhase Labs Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers (GlobeNewswire) +8.43%
03:43AM	ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains? (Zacks)
May-01-23 08:00AM	Diamond Equity Research Initiates Coverage on ProPhase Labs Inc. (NASDAQ: PRPH) (GlobeNewswire)
01:54AM	Catalent (CTLT) Stock Jumps 6.8%: Will It Continue to Soar? (Zacks)
Apr-28-23 08:30AM	ProPhase Labs CEO Ted Karkus Named One of Inc Magazines 10 Most Innovative Healthcare Leaders to Watch in 2023 (GlobeNewswire)
Apr-27-23 06:36PM	7 Small-Cap Biotech Stocks with Massive Potential (InvestorPlace)
08:03AM	Could The Market Be Wrong About ProPhase Labs, Inc. (NASDAQ:PRPH) Given Its Attractive Financial Prospects? (Simply Wall St.)
08:00AM	COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee (PR Newswire)
Apr-25-23 08:30AM	ProPhase Labs Announces Launch of Redesigned Corporate Website (GlobeNewswire)
Apr-24-23 09:00AM	Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-18-23 08:00AM	ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023 (GlobeNewswire)
Apr-10-23 03:20AM	ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock? (Zacks)
Mar-31-23 06:37AM	ProPhase Labs' (NASDAQ:PRPH) investors will be pleased with their enviable 352% return over the last three years (Simply Wall St.)
Mar-30-23 08:27AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-28-23 09:35AM	ProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022 (GlobeNewswire)
Mar-21-23 08:00AM	ProPhase Labs to Host 2022 Year End Financial Results Conference Call on Tuesday, March 28, 2023 at 11:00 a.m. Eastern Time (GlobeNewswire)
Mar-15-23 08:00AM	ProPhase Labs Announces New $6 Million Stock Repurchase Program (GlobeNewswire) +11.48%
Mar-13-23 08:00AM	ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test (GlobeNewswire)
Mar-10-23 06:52PM	Sysco Stock Deserves a Place at Your Table (Barrons.com)
Mar-07-23 08:00AM	ProPhase Labs Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test (GlobeNewswire)
Mar-01-23 08:00AM	ProPhase Labs Announces Collaboration with mProbe, Inc. and Mayo Clinic for the Continuing Development of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test (GlobeNewswire)
Feb-22-23 08:00AM	ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC) (GlobeNewswire)
Feb-16-23 08:00AM	ProPhase Labs Esophageal Cancer Early Detection Test (BE-smart) Featured in Peer-Reviewed Article in the International Journal of Molecular Science (GlobeNewswire)
Feb-15-23 08:00AM	ProPhase Labs Announces Plans for Major Expansion of its Pharmaloz Manufacturing, Inc. Subsidiary to Meet Growing Demand (GlobeNewswire)
Feb-06-23 08:00AM	ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy (GlobeNewswire)
Jan-19-23 05:55AM	While insiders own 21% of ProPhase Labs, Inc. (NASDAQ:PRPH), individual investors are its largest shareholders with 60% ownership (Simply Wall St.)
Jan-05-23 08:00AM	ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test (GlobeNewswire) -5.73%
Dec-19-22 08:30AM	ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test (GlobeNewswire)
Dec-15-22 09:12AM	Implied Volatility Surging for ProPhase Labs (PRPH) Stock Options (Zacks)
Dec-05-22 08:30AM	Stock Pitch World Cup(TM), Educational Panels and 49 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on December 6-8, 2022 (ACCESSWIRE)
Nov-30-22 08:00AM	ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022 (GlobeNewswire)
Nov-12-22 07:43AM	ProPhase Labs Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-10-22 09:35AM	ProPhase Labs, Inc. (PRPH) Q3 Earnings Miss Estimates (Zacks)
08:00AM	ProPhase Labs Announces Record Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-08-22 08:00AM	ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute (GlobeNewswire)
Nov-07-22 07:12PM	ProPhase Labs to Present at Investor Summit Groups Q4 Conference (GlobeNewswire)
Nov-04-22 08:00AM	ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time (GlobeNewswire)
Nov-01-22 09:40AM	Are Investors Undervaluing Assertio (ASRT) Right Now? (Zacks)
Oct-19-22 08:00AM	ProPhase Labs Announces Collaboration with G42 Healthcare (GlobeNewswire) -10.30%
Oct-18-22 12:19PM	ProPhase Labs, Inc.'s (NASDAQ:PRPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? (Simply Wall St.)
08:00AM	ProPhase Labs to Present at The ThinkEquity Conference (GlobeNewswire)
Oct-17-22 08:00AM	Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. (GlobeNewswire)
Sep-28-22 07:17AM	The Zacks Analyst Blog highlights Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs (Zacks)
Sep-27-22 08:11AM	5 Big Winners as Dollar Strengthens on Fed Rate Hike (Zacks)
Sep-08-22 09:40AM	Are Medical Stocks Lagging ProPhase Labs (PRPH) This Year? (Zacks)
Sep-06-22 08:15AM	ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE) (GlobeNewswire)
Aug-25-22 01:45PM	5 Cheap Healthcare Stocks in 2022 (Zacks)
12:00PM	Here's Why ProPhase Labs, Inc. (PRPH) is a Great Momentum Stock to Buy (Zacks)
Aug-23-22 09:40AM	Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year? (Zacks) -5.83%
Aug-11-22 09:25AM	ProPhase Labs, Inc. (PRPH) Tops Q2 Earnings and Revenue Estimates (Zacks) +7.58%
08:00AM	ProPhase Labs Announces Record Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-04-22 08:33PM	ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time (GlobeNewswire)
Aug-02-22 06:15PM	ProPhase Labs, Inc. (PRPH) Dips More Than Broader Markets: What You Should Know (Zacks)
Jul-28-22 03:24PM	These 10 Stocks are Gaining After Announcing Share Buybacks (Insider Monkey)
Jul-26-22 08:00AM	ProPhase Labs Announces New $6 Million Stock Repurchase Plan (GlobeNewswire) +9.09%
07:19AM	Strength Seen in ProPhase Labs, Inc. (PRPH): Can Its 8% Jump Turn into More Strength? (Zacks)
Jul-21-22 06:00PM	ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -24.71%
05:00PM	DSS Announces Licensing of Impact BioMedicals Linebacker Portfolio to ProPhase Labs (GlobeNewswire)
08:30AM	ProPhase Labs Announces Licensing of New Investigational Cancer Compounds (GlobeNewswire)
Jul-19-22 08:30AM	ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022 (GlobeNewswire)
Jul-18-22 07:38AM	These 4 Measures Indicate That ProPhase Labs (NASDAQ:PRPH) Is Using Debt Reasonably Well (Simply Wall St.)
Jul-12-22 06:30AM	Zacks.com featured highlights include USA Truck, Franklin Covey, ProPhase Labs, Daqo New Energy and The Chefs' Warehouse (Zacks) -11.56%
Jul-11-22 06:25AM	5 Stocks With Recent Price Strength for a Steady Portfolio (Zacks)

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPH

ProPhase Labs Inc

Upgrade your FINVIZ experience